Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/22/2026

Initial Management of Lower Gastrointestinal Bleeding

Initial Assessment and Risk Stratification

  • The American Gastroenterological Association recommends that all patients presenting with lower gastrointestinal bleeding (LGIB) should have their hemodynamic status assessed using shock index (heart rate/systolic BP), with a shock index >1 indicating instability 1
  • For hemodynamically stable patients, the American Gastroenterological Association suggests calculating the Oakland score to guide management decisions, which includes age, gender, previous LGIB admission, digital rectal examination findings, heart rate, systolic blood pressure, and hemoglobin level 1, 2
  • Patients with an Oakland score ≤8 points can be safely discharged for urgent outpatient investigation, according to the American Gastroenterological Association 1
  • Patients with an Oakland score >8 points should be admitted to hospital for colonoscopy, as recommended by the American Gastroenterological Association 1

Management of Hemodynamically Unstable Patients

  • For hemodynamically unstable patients (shock index >1) or those with suspected active bleeding, the American College of Radiology recommends that CT angiography (CTA) should be performed immediately as it provides the fastest and least invasive means to localize bleeding 1, 3
  • Following positive CTA, the American College of Radiology suggests that catheter angiography with embolization should be performed as soon as possible to maximize chances of success (within 60 minutes for hemodynamically unstable patients in centers with 24/7 interventional radiology) 1, 3

Transfusion Management

  • For clinically stable patients requiring red blood cell transfusion, the American Gastroenterological Association recommends using restrictive transfusion thresholds (Hb trigger 70 g/L, target 70-90 g/L) for patients without cardiovascular disease 1
  • For patients with cardiovascular disease, the American Gastroenterological Association suggests using a higher threshold (Hb trigger 80 g/L, target 100 g/L) 1

Anticoagulation Management

  • For patients on warfarin, the American Gastroenterological Association recommends interrupting warfarin therapy at presentation and reversing anticoagulation with prothrombin complex concentrate and vitamin K for unstable gastrointestinal hemorrhage 1, 4
  • For patients with low thrombotic risk, the American Gastroenterological Association suggests restarting warfarin 7 days after hemorrhage 1, 4

Antiplatelet Management

  • For patients on aspirin, the American Gastroenterological Association recommends that aspirin for primary prophylaxis should be permanently discontinued, and aspirin for secondary prevention should not be routinely stopped; if stopped, restart as soon as hemostasis is achieved 5

Common Pitfalls and Caveats

  • Failure to consider an upper GI source in patients with hemodynamic instability can lead to delayed diagnosis and treatment, according to the American College of Radiology 1, 3
  • Mortality in LGIB is generally related to comorbidity rather than exsanguination, with in-hospital mortality of 3.4% overall but rising to 18% for inpatient-onset LGIB and 20% for patients requiring ≥4 units of red cells, as reported by the American Gastroenterological Association 1, 4

Management of Lower Gastrointestinal Bleeding

Risk Stratification and Classification

  • The BLEED classification system can help identify patients at high risk of adverse in-hospital outcomes, including ongoing bleeding, low systolic blood pressure, elevated prothrombin time, erratic mental status, and unstable comorbid disease 6

Management of Identified Bleeding Sources

  • For patients with continued bleeding despite endoscopic intervention, consider angiographic embolization, and surgical intervention is indicated when active bleeding from a segmental lesion amenable to surgical cure is present 7

Initial Treatment of Lower Gastrointestinal Bleeding

Diagnostic Assessment

  • Perform digital rectal examination to confirm blood in stool and exclude anorectal pathology in patients with lower gastrointestinal bleeding, as recommended by the American Gastroenterological Association 8
  • Check for orthostatic hypotension, which indicates significant blood loss requiring ICU admission in patients with lower gastrointestinal bleeding, according to the American Gastroenterological Association 8

Management of Hemodynamically Unstable Patients

  • If patient remains unstable despite aggressive resuscitation, proceed directly to surgery, as suggested by the American Gastroenterological Association 8

Coagulopathy Correction

  • Correct coagulopathy immediately if present, by transfusing fresh frozen plasma for INR >1.5 and platelets for platelets <50,000/µL, as recommended by the American Gastroenterological Association 8

ICU Admission Criteria

  • Admit to ICU if orthostatic hypotension is present, hematocrit decrease ≥6%, transfusion requirement >2 units packed red blood cells, continuous active bleeding, or persistent hemodynamic instability despite aggressive resuscitation, as suggested by the American Gastroenterological Association 8

Management of Hemodynamically Unstable Lower GI Bleeding

Diagnostic Approach

  • The American College of Radiology recommends CT angiography (CTA) as the first diagnostic step in hemodynamically unstable patients with lower GI bleeding to rapidly localize the bleeding source before any therapeutic intervention 9, 10, 11
  • CTA provides the fastest and least invasive means to localize bleeding in unstable patients, allowing for immediate treatment planning 11
  • Following positive CTA findings, catheter angiography with embolization should be performed within 60 minutes in centers with 24/7 interventional radiology services to maximize success rates 11, 12

Intervention

  • The British Society of Gastroenterology explicitly recommends against colonoscopy as the initial approach when patients have shock index >1 or remain unstable after resuscitation, reserving it for stable patients or after successful localization and stabilization via angiography 9, 10, 11
  • The World Society of Emergency Surgery states that diagnostic laparotomy is mandatory only in unstable patients not responding to aggressive resuscitation AND after failure of other localization methods 13, 14
  • Laparotomy should be avoided unless every effort has been made to localize bleeding through radiological and endoscopic modalities 11, 13, 14

Management Algorithm

  • The American College of Radiology recommends confirming hemodynamic instability using shock index (HR/systolic BP >1) and continuing aggressive resuscitation with restrictive transfusion thresholds (Hb trigger 70 g/L for patients without cardiovascular disease, 80 g/L for those with cardiovascular disease) 11
  • Immediate CTA should be performed to localize the bleeding source, followed by catheter angiography with embolization if CTA is positive, ideally within 60 minutes 9, 10, 11, 12
  • Upper endoscopy should be considered if no lower GI source is identified, as hemodynamic instability may indicate an upper GI source 11, 12
  • Surgery should be reserved only for patients who fail angiographic intervention or continue to deteriorate despite all attempts at localization and intervention 11, 13, 14

Mortality Context

  • Mortality in lower GI bleeding is generally related to comorbidity rather than exsanguination, with overall in-hospital mortality of 3.4%, but this rises to 20% in patients requiring ≥4 units of red cells 11

Management of Hemodynamically Unstable Lower GI Bleeding

Diagnostic Approach

  • The American College of Radiology recommends CT angiography (CTA) as the initial diagnostic approach for hemodynamically unstable patients with lower GI bleeding, as it provides the fastest and least invasive means to localize bleeding before any therapeutic intervention, with a positive rate of 94% in patients with lower GI bleeding 15
  • CTA preceding transcatheter arteriography was positive in 94% of patients with lower GI bleeding, with 9 of 10 patients with positive CTA being hemodynamically unstable 15
  • Following positive CTA, catheter angiography with embolization should be performed within 60 minutes in centers with 24/7 interventional radiology services to maximize success rates, as recommended by the American College of Radiology 15

Treatment Approach

  • The American College of Radiology suggests that transcatheter embolization provides time to stabilize the patient and prepare the bowel, both of which contribute to better surgical outcomes if surgery ultimately becomes necessary 15
  • Blind segmental resection and emergency subtotal colectomy are associated with substantial rates of rebleeding (as high as 33%) and mortality (33-57%), according to the Alimentary Pharmacology and Therapeutics guidelines 16
  • Even in hemodynamically unstable patients, localization using CTA or angiography should be attempted before surgery to allow for targeted treatment rather than blind resection, as recommended by the American College of Radiology 15

Mortality Context

  • The overall operative mortality rate for emergency surgery for lower GI bleeding is 10%, with mortality rates for total abdominal colectomy ranging from 27-33%, according to the Alimentary Pharmacology and Therapeutics guidelines 16
  • Transcatheter embolization is associated with better surgical outcomes if surgery ultimately becomes necessary, as it provides time to stabilize the patient and prepare the bowel 15

Acute GI Bleed Management

Anticoagulation and Antiplatelet Management

  • The British Society of Gastroenterology recommends interrupting warfarin immediately at presentation, and for unstable hemorrhage, reversing with prothrombin complex concentrate AND vitamin K 17
  • The British Society of Gastroenterology recommends restarting warfarin at 7 days after hemorrhage for patients with low thrombotic risk 17
  • Interrupt DOAC therapy immediately at presentation, and for life-threatening hemorrhage, administer specific reversal agents (idarucizumab for dabigatran, andexanet for anti-factor Xa inhibitors) 17
  • Restart DOAC at maximum 7 days after hemorrhage 17

Organizational Requirements

  • The British Society of Gastroenterology requires all hospitals routinely admitting GI bleeding patients to have a designated GI bleeding lead clinician responsible for integrated care pathways, access to 7/7 on-site colonoscopy with endoscopic therapy capabilities, and access to 24/7 interventional radiology either on-site or via formalized referral pathway 17, 18

Timing of Endoscopy

  • Perform colonoscopy within 24 hours after adequate bowel preparation for lower GI bleeding 18

Timing of Colonoscopy in Lower Gastrointestinal Bleeding

Risk Stratification Determines Urgency

  • For hemodynamically stable patients with lower GI bleeding, the British Society of Gastroenterology recommends colonoscopy on the next available inpatient list rather than urgently within 24 hours, as urgent colonoscopy does not improve clinical outcomes including rebleeding, mortality, or length of stay 19
  • CT angiography (CTA) should be performed immediately as the first diagnostic test, NOT colonoscopy, in hemodynamically unstable patients (Shock Index >1) 20, 19
  • CTA provides the fastest and least invasive means to localize bleeding before therapeutic intervention, with a 94% positive rate in unstable patients 21, 22

Evidence Against Urgent Colonoscopy

  • The British Society of Gastroenterology guidelines state there is "no clear evidence of benefit with urgent colonoscopy (<24 hours)" and recommend colonoscopy on the next available list for stable patients 19

Diagnostic Approaches

  • Calculate the Oakland score (includes age, gender, previous LGIB admission, digital rectal examination findings, heart rate, systolic blood pressure, and hemoglobin) to determine the need for urgent colonoscopy 20
  • Oakland score ≤8 points: Discharge for urgent outpatient colonoscopy within 2 weeks (as 6% have underlying bowel cancer) 20
  • Oakland score >8 points: Admit for inpatient colonoscopy on the next available list 20, 19

Role of CTA Before Colonoscopy

  • CTA can guide colonoscopy by localizing the bleeding source, with colonoscopy identifying the culprit lesion more frequently when CTA is positive (60% vs 31%) 23, 22
  • However, routine CTA before colonoscopy in stable patients has not been shown to affect clinical outcomes (rebleeding rates, transfusion needs) 23, 22

Common Pitfalls to Avoid

  • Do not rush to colonoscopy in unstable patients - this delays definitive localization with CTA and potential embolization 21, 19
  • Do not assume bright red blood per rectum is always a lower GI source - up to 11% may be from upper GI bleeding, so consider upper endoscopy in unstable patients before proceeding to CTA 19
  • Do not forget anorectal examination - benign anorectal conditions account for 16.7% of diagnoses and should be assessed with proctoscopy or flexible sigmoidoscopy with retroflexion 20
  • Do not perform colonoscopy without adequate bowel preparation - poor preparation leads to missed lesions and need for repeat procedures 20, 19

Management of Massive Lower Gastrointestinal Bleeding in Hemodynamically Unstable Patients

Indications for Angiographic Intervention

  • Persistent bleeding despite adequate resuscitation signals the need for urgent non‑surgical intervention, such as catheter angiography with embolization. 24
  • Surgery should be reserved for patients who remain hemodynamically unstable after aggressive resuscitation, require more than six units of packed red blood cells, or experience recurrent severe bleeding. [25][26]

Coagulopathy Management

  • In the setting of active lower GI hemorrhage, fresh‑frozen plasma should be administered when the international normalized ratio exceeds 1.5, and platelet transfusion is indicated when the platelet count falls below 50 × 10⁹/L. 24

Surgical Outcomes and Risks

  • Blind segmental resection or emergency subtotal colectomy for uncontrolled lower GI bleeding are associated with re‑bleeding rates up to 33 % and mortality rates ranging from 33 % to 57 %. 26
  • The overall operative mortality for emergency surgery addressing lower GI bleeding is approximately 10 %; mortality specifically for total abdominal colectomy lies between 27 % and 33 %. 26
  • Patients aged 80–89 years have a postoperative mortality risk of about 9.8 % when undergoing surgery for lower GI bleeding. 25

Role of Nasogastric Assessment

  • Nasogastric lavage may be useful when an upper GI source is suspected, but a return of only clear fluid without bile or blood can be misleading. 27
  • Approximately 10–15 % of patients presenting with severe hematochezia have an upper gastrointestinal source of bleeding. 27

Immediate Reversal of Warfarin‑Associated Lower Gastrointestinal Bleeding with Shock

Guideline Recommendations

  • Administer 4‑factor prothrombin complex concentrate (PCC) together with low‑dose vitamin K (<5 mg) as the first‑line therapy to reverse warfarin‑induced coagulopathy in patients with life‑threatening GI hemorrhage. This recommendation is unanimous across major guidelines and is considered a strong recommendation. [28][29]

  • Do not use fresh frozen plasma (FFP) as the initial reversal agent. FFP requires ABO matching, has a slower infusion rate, and increases the risk of volume overload in hypotensive patients. This is a strong recommendation. [28][29]

  • Avoid high‑dose vitamin K (>5 mg) in the acute setting. Higher doses delay re‑anticoagulation and may increase the risk of hypercoagulability; low‑dose vitamin K facilitates earlier re‑initiation of anticoagulation when needed. Strong recommendation. [28][29]

Rationale for Prioritizing PCC

  • PCC provides rapid correction of coagulation (minutes) without the need for ABO blood‑type matching, making it ideal for emergent reversal. 28

  • PCC carries a lower risk of infectious disease transmission compared with plasma products. [28][29]

  • Crystalloid solutions (e.g., Ringer’s lactate or normal saline) may be used for initial volume resuscitation but do not correct the underlying coagulopathy and can further dilute clotting factors. Hence, crystalloids are adjuncts, not primary therapy. [28][29]

Immediate Resuscitation Algorithm

Step Intervention Context / Target
1 Give 4‑factor PCC (dose per institutional protocol) Immediate reversal of warfarin‑induced coagulopathy in shock.
1 Give vitamin K < 5 mg IV (or oral if IV unavailable) concurrently Restores endogenous factor VII (half‑life ≈ 4 h); low dose permits earlier re‑anticoagulation if thrombotic risk is high.
2 Transfuse packed red blood cells (PRBC) as needed Restore oxygen‑carrying capacity after coagulopathy is corrected; volume guided by hemodynamic response and hemoglobin targets.
3 Provide limited crystalloid bolus (Ringer’s lactate or normal saline) if additional volume needed Supports perfusion while avoiding excessive dilutional coagulopathy.
4 Consider FFP only if INR remains >1.5 after PCC administration Reserved for refractory coagulopathy; not first‑line.
5 Give platelets if platelet count <50 × 10⁹/L Corrects thrombocytopenia that may impede hemostasis.

Timing of Warfarin Resumption

  • Restart warfarin on day 7 after hemostasis for patients with low thrombotic risk. This timing balances bleeding risk with the need for anticoagulation. Strong recommendation. [28][29]

  • For patients at high thrombotic risk (e.g., mechanical mitral valve), consider earlier restart on day 3 after stable hemostasis. Strong recommendation. [28][29]

  • Use unfractionated heparin as a bridging agent in high‑risk patients because of its short half‑life (1–2 h), allowing rapid reversal if re‑bleeding occurs. Moderate recommendation. 28

Pitfalls to Avoid (Evidence‑Based)

  • Never postpone PCC administration while awaiting imaging or endoscopy. Immediate reversal is essential for survival. Strong recommendation. [28][29]

  • Do not select FFP as the first‑line reversal product. It is slower, requires matching, and adds fluid load. Strong recommendation. [28][29]

  • Avoid high‑dose vitamin K (>5 mg) in the acute phase. It delays re‑anticoagulation and may predispose to hypercoagulability. Strong recommendation. [28][29]

Initial Management of Acute Lower Gastrointestinal Bleeding in Hemodynamically Unstable Patients

Diagnostic Approach

  • Nasogastric tube placement is appropriate only when an upper gastrointestinal source is suspected; the presence of maroon‑colored stool strongly suggests a lower gastrointestinal source. (World Journal of Emergency Surgery, 2021) 30
  • Colonoscopy requires adequate bowel preparation and therefore should not be performed as the initial diagnostic test in unstable patients; it is reserved for stable patients after bleeding has been localized and the patient is hemodynamically optimized. (World Journal of Emergency Surgery, 2021) 30

Resuscitation and Coagulopathy Management

  • Correct coagulopathy promptly: administer fresh‑frozen plasma when INR > 1.5 and platelet transfusion when platelet count < 50 × 10⁹/L. (Alimentary Pharmacology & Therapeutics, 2005) 31

Imaging and Endovascular Therapy

  • CT angiography can detect active bleeding at rates as low as 0.3 mL/min, making it the fastest, least invasive localization tool for unstable patients. (World Journal of Emergency Surgery, 2021) 30
  • If CTA is positive, catheter‑directed angiography with embolization should be performed within 60 minutes; embolization achieves immediate hemostasis in approximately 40–100 % of cases. (World Journal of Emergency Surgery, 2021) 30

Indications for Surgical Intervention

  • Surgery is indicated only when the patient remains unstable despite successful localization and endovascular therapy; blind segmental resection without prior localization carries high re‑bleeding (≈ 33 %) and mortality (33–57 %) rates. (World Journal of Emergency Surgery, 2021) 30
  • When surgery is unavoidable, emergency subtotal colectomy carries a mortality of 27–33 %. (World Journal of Emergency Surgery, 2021) 32

Upper Gastrointestinal Source Considerations in Severe Hematochezia

Prevalence of Upper GI Bleeding

  • In patients presenting with severe hematochezia, approximately 10–15 % have an upper gastrointestinal source, underscoring the need to keep an upper GI etiology in the differential diagnosis. 33

Nasogastric Tube Assessment

  • Nasogastric tube (NGT) placement is indicated only when there is a moderate‑to‑low suspicion of an upper GI source; the presence of maroon‑colored stool strongly points toward a lower GI origin and makes routine NGT placement unnecessary. 33
  • NGT lavage results can be misleading: a return of clear fluid without bile does not reliably exclude an upper GI bleed, limiting the diagnostic value of NGT in this context. 33

Role of Upper Endoscopy after Negative CTA

  • When CT angiography (CTA) is negative but bleeding persists, an upper endoscopy should be performed to exclude an upper GI source, given that up to 15 % of severe hematochezia cases are attributable to upper GI bleeding. 33

Even when maroon stools suggest a lower GI origin, clinicians should maintain a high index of suspicion for an upper GI source because *up to 15 % of severe hematochezia originates from the upper gastrointestinal tract**. 33

Management of Hemodynamically Unstable Lower Gastrointestinal Bleeding

Immediate Resuscitation and Coagulopathy Correction

  • Aggressive resuscitation with crystalloids and blood products should be continued while diagnostic localization is pursued (American College of Radiology) 34.
  • Coagulopathy must be corrected promptly: transfuse fresh‑frozen plasma for INR > 1.5 and platelets for platelet count < 50 × 10³/µL (Alimentary Pharmacology & Therapeutics) 35.

First‑Line Diagnostic Localization

  • CT angiography (CTA) is the recommended initial diagnostic test for patients who are hemodynamically unstable (shock index > 1); colonoscopy or laparotomy are not appropriate first steps (American College of Radiology) 34.
  • CTA demonstrates a sensitivity of ≈ 94 % for detecting active lower‑GI bleeding in unstable patients (American College of Radiology) 34.
  • CTA can identify bleeding rates as low as 0.3 mL/min, outperforming conventional angiography, which requires ≥ 1 mL/min (American College of Radiology) 34.
  • If CTA fails to reveal a lower‑GI source, an upper endoscopy should be performed before any surgical intervention (American College of Radiology) 34.

Endovascular Therapy

  • When CTA is positive, catheter angiography with embolization should be performed within 60 minutes to maximize technical success (American College of Radiology) 34.
  • Transcatheter embolization achieves immediate hemostasis in 40–100 % of cases and buys time for patient stabilization and bowel preparation for possible later surgery (American College of Radiology) 34.
  • Endovascular localization and embolization are recommended before any operative approach, even in patients who remain unstable (American College of Radiology; World Society of Emergency Surgery–AAST) [34][36]37.

Surgical Indications and Contraindications

  • Laparotomy is reserved as a last resort and is indicated only when the patient remains unstable despite successful localization and endovascular therapy, or after failure of angiographic embolization (American College of Radiology; World Society of Emergency Surgery–AAST) [34][36]37.
  • Surgery without prior localization should be performed only for uncontrollable bleeding in a patient who is actively deteriorating despite maximal resuscitation (American College of Radiology; World Society of Emergency Surgery–AAST) [34][37].
  • Blind segmental resection or emergency subtotal colectomy without prior localization carries re‑bleeding rates up to 33 % and mortality 33–57 %; emergency total colectomy mortality is 27–33 % versus ~10 % when bleeding is first localized (American College of Radiology) 34.
  • Diagnostic laparotomy is mandatory only after failure of all non‑operative localization methods and persistent hemodynamic instability despite aggressive resuscitation (World Society of Emergency Surgery–AAST) [36][37].

Contraindications to Colonoscopy in Unstable Patients

  • Colonoscopy is contraindicated in hemodynamically unstable patients (shock index > 1) (American College of Radiology) 34.
  • Adequate bowel preparation (4–6 L polyethylene glycol over 3–4 h) is not feasible in unstable patients, further precluding colonoscopy (American College of Radiology) 34.
  • A systematic review found that urgent colonoscopy does not improve re‑bleeding, mortality, or length of stay compared with elective colonoscopy (American College of Radiology) 34.
  • Colonoscopy should be reserved for stable patients or after successful localization and stabilization via angiography (American College of Radiology) 34.

Evidence Strength and Guideline Sources

  • The 2021 ACR Appropriateness Criteria provide high‑quality, evidence‑based recommendations supporting CTA followed by angiography/embolization as first‑line management (American College of Radiology) 34.
  • The 2021 WSES‑AAST Guidelines similarly endorse this algorithm and define surgical indications as a last resort (World Society of Emergency Surgery–AAST) [36][37].
  • The 2005 Alimentary Pharmacology & Therapeutics guideline (grade C evidence) advises that unstable patients with severe, unremitting bleeding should forego nuclear scintigraphy and proceed directly to resuscitation and angiography (Alimentary Pharmacology & Therapeutics) 38.

Warfarin Resumption After Life‑Threatening Bleeding

Low Thrombotic‑Risk Patients

  • In patients with low risk of thrombosis, warfarin should be restarted approximately 7 days after achieving hemostasis to balance bleeding and clotting risks. 39

High Thrombotic‑Risk Patients

  • For patients at high risk of thrombosis (e.g., mechanical mitral valve, recent venous thromboembolism within 3 months), bridging anticoagulation with low‑molecular‑weight heparin can be initiated about 48 hours after stable hemostasis, followed by warfarin resumption once therapeutic INR is reached. 39

Management of Acute Lower Gastrointestinal Bleeding

Clinical Presentation & Risk Assessment

  • Bright or dark red blood per rectum, blood clots, or blood mixed with stool are the typical manifestations of lower gastrointestinal bleeding. 40
  • Within the first hour of evaluation, a systolic blood pressure < 100 mmHg or a heart rate > 100 beats/min predicts severe bleeding. 41
  • Presence of gross blood on the initial digital rectal examination is an independent predictor of severe bleeding. 41
  • Syncope at presentation correlates with severe bleeding. 41
  • High‑risk features for severe bleeding include:

Approximately 10–15 % of patients with severe hematochezia have an upper‑GI source, especially when hemodynamic instability, prior peptic ulcer disease, or portal hypertension are present. 40

Diagnostic Approach

Hemodynamically Unstable Patients (Shock Index > 1)

  • CT angiography (CTA) should be performed immediately as the first diagnostic test; it has a sensitivity of ≈ 94 % and can detect bleeding rates as low as 0.3 mL/min. 40, 42
  • If CTA identifies a bleeding source, catheter angiography with embolization must be undertaken within 60 minutes to maximize technical success. 42
  • When CTA fails to locate a lower‑GI source, an upper endoscopy is recommended before any surgical intervention because up to 15 % of severe hematochezia originates from the upper tract. 40
  • Colonoscopy is contraindicated in unstable patients because adequate bowel preparation is not feasible and urgent colonoscopy does not improve re‑bleeding, mortality, or length of stay. 40

Hemodynamically Stable Patients

  • Inpatient colonoscopy on the next available list (not urgently within 24 hours) is recommended; urgent colonoscopy does not improve clinical outcomes. 40
  • After rapid bowel cleansing, colonoscopy achieves a diagnostic accuracy of ≈ 72–86 % and remains the preferred modality for acute lower‑GI bleeding in stable patients. 40

Therapeutic Strategies

Endoscopic Management

  • Diverticular bleeding: Visible vessels or adherent clots (stigmata of recent bleeding) reliably predict severe hemorrhage, whereas a clean‑based ulcer within a diverticulum indicates low re‑bleeding risk. 41
  • Post‑polypectomy bleeding:
  • Colonic angiodysplasia: Injection of 1:10,000 adrenaline before bipolar or heater‑probe coagulation is recommended; extra caution is required for cecal lesions to avoid perforation. 43
  • Radiation proctitis (chronic rectal bleeding): Heater‑probe or bipolar electrocoagulation are equally effective, both reducing severe bleeding and improving symptoms at 6 months. 43

Common Pitfalls (Evidence‑Based)

  • Do not rush to colonoscopy in hemodynamically unstable patients; doing so delays definitive localization with CTA and potential embolization. 40
  • Do not assume bright red rectal bleeding is always lower‑GI; up to 15 % may stem from an upper‑GI source. 40

Evidence level: The cited studies provide observational and cohort data; specific grades of recommendation were not detailed in the source material.

Immediate CT Angiography in Acute Massive Lower Gastrointestinal Bleeding

Diagnostic Imaging

  • CT angiography (CTA) should be performed immediately as the first diagnostic test in patients with massive ongoing lower gastrointestinal hemorrhage and hemodynamic instability (shock index > 1). This recommendation is based on evidence that CTA rapidly localizes bleeding without the need for bowel preparation, making it the fastest and least invasive option for unstable patients. 44

  • CTA provides a sensitivity of 94 % for detecting active bleeding and can identify bleeding rates as low as 0.3 mL/min. These performance characteristics support its use as the primary imaging modality in the acute setting. 44

  • When CTA identifies a bleeding source, catheter angiography with embolization should be undertaken within 60 minutes in centers that have 24/7 interventional radiology services. Prompt transition from diagnosis to therapeutic embolization minimizes ongoing blood loss. 44

  • If CTA fails to reveal a lower‑GI source, upper endoscopy is recommended because 10–15 % of patients presenting with severe hematochezia actually have an upper‑GI origin. This step ensures that an occult upper‑GI bleed is not missed. 44

  • Risk factors that increase the likelihood of an upper‑GI source despite hematochezia include brisk bleeding with shock, a history of peptic ulcer disease, portal hypertension, an elevated BUN/creatinine ratio, and the use of antiplatelet agents. Recognizing these factors guides the decision to proceed to upper endoscopy after a negative CTA. 44

Nasogastric Tube (NGT) Use

  • Routine placement of a nasogastric tube is not recommended in suspected lower‑GI bleeding. It does not reliably aid diagnosis, does not improve clinical outcomes, and insertion is technically difficult in up to one‑third of patients. 44

  • NGT should be reserved only for cases where an upper‑GI source is strongly suspected; it is unnecessary when clinical features (e.g., maroon‑colored stool) point toward a lower‑GI origin. This avoids unnecessary procedures and potential complications. 44

Management of Unstable Lower Gastrointestinal Bleeding

Imaging and Endovascular Therapy

  • The 2021 American College of Radiology (ACR) Appropriateness Criteria recommend that, in hemodynamically unstable patients with massive lower‑GI bleeding and no peritoneal signs, contrast‑enhanced CT angiography should be performed first, followed immediately by catheter‑based embolization when a bleeding source is identified. This recommendation is based on expert consensus and published guideline methodology【45】.

  • When a vascular bleeding source (e.g., diverticular disease or angiodysplasia) is identified, trans‑catheter embolization achieves hemostasis in approximately 40 %–100 % of cases according to the same ACR guideline, reflecting a wide range of success depending on lesion type and operator experience【46】.

  • If the CT angiogram is positive, catheter angiography with embolization should be initiated within 60 minutes of imaging to maximize the chance of rapid bleeding control, as stipulated by the ACR 2021 recommendations【46】.

Endoscopic Contraindications

  • The ACR 2021 guidelines state that colonoscopy is contraindicated in patients who remain hemodynamically unstable (shock index > 1) because the procedure requires bowel preparation and sedation that can worsen shock, and it does not address the underlying source of massive bleeding【45】.

Surgical Intervention

  • According to the ACR Appropriateness Criteria (2021), surgery is reserved as a “last‑resort” therapy and should be considered only after failure of endovascular control (e.g., unsuccessful embolization) or when the patient continues to deteriorate despite optimal resuscitation and angiographic attempts【45】.

  • The same guideline notes that surgery becomes appropriate when alternative therapeutic tools such as repeat colonoscopy or trans‑catheter embolization are not feasible or unavailable, emphasizing that operative management is indicated only after other modalities have been exhausted or are contraindicated【45】.

Management of Bright Red Hematochezia According to Hemodynamic Status

Immediate Hemodynamic Assessment

Diagnostic Pathway for Unstable Patients (Shock Index > 1)

Imaging and Immediate Therapy

Upper‑GI Evaluation

Contraindication of Colonoscopy

Clinical Pitfall

Diagnostic Pathway for Stable Patients (Shock Index ≤ 1)

Initial Anorectal Evaluation

Risk Stratification with the Oakland Score

Colonoscopy After Adequate Bowel Preparation

Initial Resuscitation and Laboratory Assessment

Advanced Imaging for Persistent Bleeding

Surgical Considerations (Last‑Resort)

Common Pitfalls to Avoid

Calcium and Albumin Management in Acute Post‑Colonoscopy Bleeding

Calcium Replacement and Monitoring

  • When ionized calcium is < 0.9 mmol/L (or corrected total calcium < 7.5 mg/dL), give calcium chloride 10 mL of a 10 % solution (≈ 270 mg elemental calcium) rather than calcium gluconate, because calcium chloride is preferred in patients with possible hepatic impairment. [52][53]
  • Ionized calcium < 0.8 mmol/L is linked to cardiac dysrhythmias and therefore requires prompt correction. [52][53]
  • Calcium serves as a crucial cofactor for clotting factors II, VII, IX, X and supports platelet adhesion at sites of vascular injury, so adequate calcium levels are essential for effective hemostasis. [52][53]

Interpretation of Low Albumin in the Acute Bleeding Setting

  • A serum albumin of ~3.7 g/dL together with low total protein after a colonoscopic procedure most likely reflects acute blood loss and hemodilution from resuscitation rather than chronic malnutrition. 54
  • Albumin behaves as an acute‑phase reactant, decreasing during active bleeding and systemic inflammation; consequently, it is not a reliable marker of malnutrition or malabsorption in the immediate post‑bleeding period. 55

Post‑Polypectomy Bleeding Epidemiology

  • Post‑polypectomy bleeding occurs in up to 2.5 % of colonoscopies; delayed bleeding may appear up to 15 days after the procedure but resolves spontaneously in more than 70 % of cases. 55

Management of Acute Massive Lower Gastrointestinal Bleeding with Hemodynamic Instability

Immediate Resuscitation

  • Aggressive intravenous crystalloid resuscitation (normal saline or Ringer’s lactate) should be initiated promptly to normalize blood pressure and heart rate before any diagnostic procedure. 56
  • A restrictive transfusion strategy is recommended: maintain hemoglobin > 7 g/dL in patients without cardiovascular disease and > 8–9 g/dL in those with cardiovascular disease or massive bleeding. 57
  • Coagulopathy must be corrected immediately; give fresh‑frozen plasma when INR > 1.5 and platelet transfusion when platelet count < 50 × 10³/µL. 57

Diagnostic Imaging

  • In hemodynamically unstable patients (shock index > 1), a contrast‑enhanced CT angiography (CTA) should be performed as the first diagnostic test. Positive CTA findings must trigger rapid endovascular intervention. 57

Endovascular Therapy

  • When CTA identifies a bleeding source, catheter‑directed angiography with embolization should be performed within 60 minutes; embolization achieves immediate hemostasis in 40 %–100 % of cases. 57

Colonoscopy (Stable Patients)

  • In stable patients, urgent colonoscopy performed within 24 hours does not reduce re‑bleeding, mortality, or length of stay compared with elective colonoscopy. Therefore, colonoscopy is not indicated in the unstable phase. 57

Surgical Intervention (Last Resort)

  • Surgery is reserved for patients who fail endovascular control or who deteriorate despite maximal resuscitation and angiographic attempts.
  • Blind segmental resection or emergency subtotal colectomy without prior localization carries re‑bleeding rates up to 33 % and mortality 33 %–57 %. 57
  • Emergency total colectomy has a mortality of 27 %–33 % versus approximately 10 % when bleeding is first localized by imaging. 57

Anticoagulation Management

  • For patients on warfarin experiencing unstable hemorrhage, the anticoagulant should be stopped immediately and reversed with prothrombin complex concentrate plus vitamin K. 57

Role of Nasogastric Tube

  • Maroon‑colored stool strongly suggests a lower gastrointestinal source; therefore, routine nasogastric tube placement is unnecessary in this scenario. 56

Management of Hemodynamically Stable Lower Gastrointestinal Bleeding

Risk Stratification and Initial Assessment

  • In hemodynamically stable patients with lower gastrointestinal bleeding, calculate the Oakland score; a score ≤ 8 supports discharge for urgent outpatient colonoscopy within 2 weeks (≈6 % have underlying colorectal cancer), whereas a score > 8 warrants admission for inpatient colonoscopy on the next available list. Urgent colonoscopy within 24 hours does not improve rebleeding, mortality, or length of stay. 58
  • A shock index (heart rate ÷ systolic blood pressure) > 1 defines hemodynamic instability and mandates computed‑tomography angiography rather than colonoscopy. 58
  • Digital rectal examination should be performed to confirm the presence of blood, exclude anorectal pathology (accounting for ~16 % of diagnoses), and identify gross blood, which independently predicts severe bleeding. 58

Resuscitation and Transfusion Strategy

  • Apply a restrictive transfusion strategy: for patients without cardiovascular disease, use a hemoglobin trigger of ≈ 70 g/L and target 70–90 g/L. 58
  • For patients with cardiovascular disease, use a hemoglobin trigger of ≈ 80 g/L and aim for a target ≥ 100 g/L. 58

Colonoscopy Timing and Bowel Preparation

  • Schedule colonoscopy on the next available inpatient list; performing colonoscopy urgently within 24 hours does not confer benefit in rebleeding, mortality, or length of stay compared with elective timing. 58
  • Provide adequate bowel preparation with 4–6 L of polyethylene glycol administered over 3–4 hours; inadequate preparation leads to missed lesions, repeat procedures, and diagnostic failure rates up to 70 %, and emergency colonoscopy without proper prep results in a 70 % repeat‑procedure rate and 50 % of patients requiring a third colonoscopy. 58

Anticoagulation and Antiplatelet Management

  • For patients on warfarin, interrupt therapy immediately on presentation; in unstable hemorrhage, reverse with prothrombin complex concentrate plus vitamin K. Restart warfarin at 7 days for low thrombotic risk and at 3 days for high thrombotic risk (e.g., mechanical mitral valve). 58
  • Patients taking aspirin for secondary cardiovascular prevention should generally continue aspirin; if stopped, restart within 5 days or as soon as hemostasis is achieved. 58
  • Aspirin used for primary prophylaxis should be permanently discontinued. 58
  • In patients on dual antiplatelet therapy, continue aspirin; the P2Y12 inhibitor may be continued or temporarily held based on bleeding severity and ischemic risk, but should be restarted within 5 days if interrupted. 58
  • For patients on direct oral anticoagulants, interrupt therapy immediately; in life‑threatening hemorrhage, administer specific reversal agents (idarucizumab for dabigatran, andexanet alfa for factor Xa inhibitors). 58

Critical Pitfalls and Safety Considerations

  • Bright‑red rectal bleeding may originate from an upper gastrointestinal source in 10–15 % of cases, especially in patients with hemodynamic instability, prior peptic ulcer disease, or portal hypertension. 58
  • Colonoscopy is contraindicated when the shock index exceeds 1; in such cases, computed‑tomography angiography should be pursued for localization and possible embolization. 58
  • Blind surgical segmental resection without prior radiologic localization carries rebleeding rates of ≈ 33 % and mortality of 33–57 %, compared with ~10 % when bleeding is first localized radiologically. 58
  • Overall in‑hospital mortality for lower gastrointestinal bleeding is ≈ 3.4 %, rising to ≈ 20 % in patients requiring ≥ 4 units of packed red blood cells. 58

Initial Resuscitation and Early Management of Acute Lower Gastrointestinal Bleeding with Hemodynamic Compromise

Immediate Resuscitation Protocol

  • Resuscitation must be performed concurrently with the initial clinical evaluation and must always precede any diagnostic procedure. 59
  • Two large‑bore intravenous catheters should be placed immediately and aggressive crystalloid infusion (normal saline or Ringer’s lactate) started to restore blood pressure and heart rate. 59
  • Packed red blood cells are indicated when hemoglobin falls below 100 g/L (10 g/dL) in the setting of acute bleeding; mortality rises with increasing severity of anemia. 60
  • After hemodynamic stabilization, a restrictive transfusion strategy is recommended: maintain hemoglobin > 70 g/L in patients without cardiovascular disease, and target > 80 g/L (aiming for 100 g/L) in patients with hypertension or other cardiovascular risk factors. 61
  • Coagulopathy should be corrected promptly: transfuse fresh‑frozen plasma when INR > 1.5 and platelets when the count is < 50 × 10⁹/L. 62

Timing and Indications for Colonoscopy

  • Colonoscopy is contraindicated until adequate hemodynamic resuscitation has been achieved. 59
  • Adequate bowel preparation requires 4–6 L of polyethylene glycol administered over 3–4 hours, which is not feasible in an actively bleeding, unstable patient. 63
  • Performing colonoscopy within 24 hours of presentation does not reduce re‑bleeding rates, mortality, or length of hospital stay compared with elective colonoscopy after stabilization. 64
  • Colonoscopy is explicitly contraindicated when the shock index exceeds 1.0 or when the patient remains unstable after the initial resuscitation effort. 64

Diagnostic Imaging After Stabilization

  • If the patient remains unstable after resuscitation, a contrast‑enhanced CT angiography should be the first diagnostic test; it has a sensitivity of ≈94 % and can detect bleeding as low as 0.3 mL/min. 61
  • When CT angiography identifies a bleeding source, catheter‑directed angiography with embolization should be performed within 60 minutes; technical success rates range from 40 % to 100 %. 61
  • Once the patient is hemodynamically stable, colonoscopy can be scheduled on the next available inpatient list after completing the required bowel preparation. 64
  • Colonoscopy remains essential for patients with known colorectal polyps, providing both diagnostic information and therapeutic options such as clipping, cautery, or band ligation of bleeding lesions. 59

Key Clinical Pitfalls to Avoid

  • Endoscopic evaluation must never be undertaken before achieving stable blood pressure and central venous pressure. 60
  • Bright‑red hematochezia does not always indicate a lower‑GI source; 10–15 % of severe cases originate from the upper GI tract. If CT angiography is negative for a lower‑GI bleed, an upper endoscopy should be performed before considering surgery. 63
  • Blind surgical exploration without prior localization leads to re‑bleeding in up to 33 % of cases and mortality of 33–57 %, whereas radiologic localization reduces these rates to ≈10 %. 59
  • Ongoing massive transfusion (≥ 6 units of packed red cells) or persistent instability despite aggressive resuscitation should prompt immediate angiography or operative intervention rather than colonoscopy. 59

Management of Blood Pressure and Vasopressors

  • Elevated systolic blood pressure during active hemorrhage should not be aggressively lowered; a degree of hypertension may be compensatory to maintain organ perfusion. 60
  • Vasopressors should be avoided whenever possible; they are reserved only to prevent fluid overload or abdominal compartment syndrome because they may impair mesenteric perfusion. 65

Hemodynamic Assessment

  • Shock index (heart rate ÷ systolic blood pressure) is calculated as 110 ÷ 160 ≈ 0.69; although numerically < 1, accompanying tachycardia, pallor, and brisk rectal bleeding indicate significant ongoing blood loss and justify aggressive resuscitation. 61

Management Algorithm for Massive Lower Gastrointestinal Bleeding When CT Angiography Is Negative

Assessment and Decision Pathway

  • In an elderly patient with chronic alcohol use presenting with massive bright‑red rectal bleeding and a negative contrast‑enhanced CT scan, the next step is urgent colonoscopy after rapid bowel preparation if the patient is hemodynamically stable; if the patient remains unstable despite resuscitation, immediate catheter angiography is indicated. 66
  • Hemodynamic instability is defined by a shock index > 1 (heart rate ÷ systolic blood pressure); in such patients colonoscopy is contraindicated because it requires 4–6 L of polyethylene glycol bowel preparation over 3–4 h, sedation that can worsen shock, and does not directly control massive bleeding. 66

Imaging Considerations

  • Conventional catheter angiography should be performed directly even when the prior CT angiography is negative, because angiography can detect active bleeding at rates ≥ 1 mL/min (versus ≥ 0.3 mL/min required for detection on CTA), and intermittent bleeding may have been missed on the initial CT. 66
  • CT angiography has an overall sensitivity of approximately 94 % but only when bleeding is actively occurring at ≥ 0.3 mL/min at the exact moment of imaging; therefore a negative CTA does not exclude a lower‑GI source. 66

Interventional Options

  • Transcatheter embolization performed during angiography achieves immediate hemostasis in 40 %–100 % of cases, providing rapid bleeding control and allowing time for subsequent bowel preparation, colonoscopy, or surgery if needed. 66

Endoscopic Management for Stable Patients

  • When the patient is hemodynamically stable (shock index ≤ 1), urgent colonoscopy after rapid bowel preparation with 4–6 L of polyethylene glycol administered over 3–4 h is the recommended next step. 66

Guideline Recommendations

  • The 2021 American College of Radiology (ACR) Appropriateness Criteria and the British Society of Gastroenterology (BSG) guidelines state that urgent colonoscopy performed within 24 hours does not improve re‑bleeding rates, mortality, or length of stay compared with elective colonoscopy; however, in patients who have already required multiple transfusions, performing colonoscopy on the next available inpatient list is appropriate. 66
  • If colonoscopy is negative and bleeding persists, an upper endoscopy must be performed before any surgical intervention to exclude an upper‑GI source. 66

Acute Lower Gastrointestinal Bleeding – Immediate Resuscitation and Diagnostic Prioritization

Immediate Hemodynamic Management

  • Aggressive intravenous crystalloid infusion combined with packed red blood cell transfusion should be initiated before any diagnostic procedure to restore hemodynamic stability in older adults presenting with acute bright‑red rectal bleeding. 67
  • Although a shock index < 1 (e.g., heart rate ≈ 110 bpm ÷ systolic BP ≈ 160 mm Hg = 0.69) suggests less frank instability, the presence of tachycardia, pallor and ongoing brisk bleeding mandates immediate aggressive resuscitation. 67

Transfusion and Blood‑Product Strategies

  • A restrictive transfusion strategy is advised: maintain hemoglobin > 70 g/L in patients without cardiovascular disease, but target > 80 g/L (aiming for ≈ 100 g/L) in those with hypertension or other cardiovascular risk factors. 67
  • Fresh‑frozen plasma should be administered when the international normalized ratio exceeds 1.5, and platelet transfusion when the platelet count falls below 50 × 10⁹/L. 68

Bowel Preparation and Colonoscopy Timing

  • Adequate bowel preparation for colonoscopy requires 4–6 L of polyethylene glycol administered over 3–4 hours, which is not feasible in an actively bleeding, unstable patient. 69
  • Performing colonoscopy within 24 hours of presentation does not reduce re‑bleeding rates, mortality, or length of hospital stay compared with elective colonoscopy after hemodynamic stabilization. 69

Diagnostic Imaging Prioritization

  • Computed tomography angiography (CTA) should be reserved for patients who remain hemodynamically unstable (shock index > 1) after initial resuscitation or when active bleeding is strongly suspected. 69
  • CTA is preferred over colonoscopy in unstable patients because it can localize bleeding without the need for bowel preparation, is widely available, and can be performed rapidly. 69
  • CTA has a sensitivity of approximately 94 % and can detect bleeding as low as 0.3 mL/min. 69
  • If CTA identifies a bleeding source, catheter‑directed angiography with embolization should be performed within 60 minutes; technical success rates range from 40 % to 100 %. [69][68]
  • When CTA is negative for a lower‑GI source, upper endoscopy is recommended because 10–15 % of severe hematochezia originates from the upper gastrointestinal tract. 69

Clinical Pitfalls to Avoid

  • Do not proceed to colonoscopy or CTA before achieving hemodynamic stability, as this delays definitive resuscitation and may worsen shock. 69
  • Bright‑red rectal bleeding does not always indicate a lower‑GI origin; up to 15 % may arise from an upper‑GI source, especially in the setting of instability. 69
  • Blind surgical exploration without prior radiologic localization leads to re‑bleeding in up to 33 % of cases and mortality of 33–57 %; radiologic localization reduces these rates to ≈ 10 %. 69

Outcomes and Mortality

  • Overall in‑hospital mortality for lower gastrointestinal bleeding is ≈ 3.4 %, rising to ≈ 20 % in patients requiring ≥ 4 units of packed red blood cells. 67
  • Mortality is more closely related to underlying comorbidities than to exsanguination, highlighting the importance of optimal hemodynamic management and treatment of coexisting conditions. 67

Acute Lower Gastrointestinal Bleeding Presenting with Bright‑Red Blood and Clots

Immediate Hemodynamic Assessment

  • Calculate the shock index (heart rate ÷ systolic blood pressure) to assess stability; a value > 1 indicates hemodynamic instability and mandates urgent emergency‑department evaluation and CT angiography rather than colonoscopy. [70][71]
  • Shock index > 1 defines an unstable patient; shock index ≤ 1 defines a stable patient suitable for further risk stratification. [70][71]
  • Performing a digital rectal examination that confirms the presence of blood independently predicts severe bleeding. 70

Management of Hemodynamically Unstable Patients (Shock Index > 1)

  • CT angiography should be the first imaging modality; colonoscopy is contraindicated when the shock index exceeds 1. 70
  • If CT angiography fails to locate a lower‑GI source, an upper endoscopy is required because 10–15 % of severe bright‑red rectal bleeding actually originates from the upper gastrointestinal tract. 72

Management of Hemodynamically Stable Patients (Shock Index ≤ 1)

  • Use the Oakland score to decide disposition:
    • An Oakland score ≤ 8 permits discharge with an urgent outpatient colonoscopy scheduled within 2 weeks; approximately 6 % of these patients are later found to have colorectal cancer. 70
    • An Oakland score > 8 warrants hospital admission for an inpatient colonoscopy; performing the colonoscopy urgently (within 24 h) does not improve outcomes compared with routine scheduling. 70
  • The Oakland score incorporates age, gender, prior lower‑GI bleeding admission, digital rectal exam findings, heart rate, systolic blood pressure, and hemoglobin level (the latter explicitly cited). 70

Red‑Flag Features Requiring Immediate Emergency Care

  • Shock index > 1 (heart rate divided by systolic blood pressure). [70][71]
  • Active use of anticoagulants (warfarin or direct oral anticoagulants) with ongoing bleeding. [70][71]

Resuscitation and Transfusion Strategy

  • Adopt a restrictive transfusion approach targeting a hemoglobin level > 70 g/L (or > 80 g/L in patients with cardiovascular disease). 70

Anticoagulation Management

  • Warfarin: discontinue immediately; reverse with prothrombin‑complex concentrate plus vitamin K for unstable bleeding; consider restarting after 7 days in low‑risk thrombotic patients. [70][71]
  • Direct oral anticoagulants: discontinue immediately; employ specific reversal agents (idarucizumab for dabigatran, andexanet alfa for factor Xa inhibitors) in life‑threatening bleeding; restart no later than 7 days. [70][71]
  • Aspirin: continue if prescribed for secondary cardiovascular prevention; stop if used solely for primary prevention. [70][71]

Mortality and Prognostic Context

  • Overall in‑hospital mortality for lower‑GI bleeding is 3.4 %; mortality rises to 20 % among patients who require ≥ 4 units of red blood cells, reflecting the impact of comorbidities rather than exsanguination alone. 70

Consideration of Upper‑GI Sources

  • Up to 15 % of severe bright‑red rectal bleeding may arise from the upper gastrointestinal tract, particularly in the setting of hemodynamic instability, peptic ulcer disease, or portal hypertension. 72

Urgent Hospital Evaluation for Patients with Hematochezia and Hemodynamic Instability

Coagulopathy Management

  • In patients with active gastrointestinal bleeding, an international normalized ratio > 1.5 or a platelet count < 50 × 10⁹/L necessitates immediate correction of coagulopathy, which can only be reliably performed in an acute‑care setting. [73][74]

Imaging and Endovascular Intervention

Initial Imaging for Unstable Patients

  • For individuals with a shock index > 1, computed‑tomography angiography (CTA) is the mandatory first diagnostic test; CTA demonstrates a 94 % sensitivity for detecting bleeding rates as low as 0.3 mL/min. 74

Endovascular Therapy

  • When CTA identifies a bleeding source, catheter‑directed angiography with embolization should be undertaken within 60 minutes; reported hemostasis success rates range from 40 % to 100 %. 74

Evaluation When No Lower‑GI Source Is Found

  • If CTA fails to reveal a lower‑gastrointestinal origin, an urgent upper endoscopy is required because 10 %–15 % of severe bright‑red rectal bleeding actually stems from the upper gastrointestinal tract. 74

Upper‑GI Source Consideration

  • Approximately 15 % of presentations with bright‑red rectal bleeding are attributable to upper‑GI pathology, a proportion that rises markedly in patients with hemodynamic instability. 74

Risks of Non‑Localized Surgical Intervention

  • Performing blind surgical exploration in patients with a shock index > 1, without prior localization of the bleeding source, is associated with a mortality rate of 33 %–57 %. 74

Urgent Endoscopic Evaluation for Hematochezia with Falling Hemoglobin

Epidemiology of Upper‑GI Sources

  • Up to 15 % of severe hematochezia actually originates from the upper gastrointestinal tract, a proportion that rises in hemodynamically unstable patients. 75

Immediate Hemodynamic Assessment

  • Calculate the shock index (heart rate ÷ systolic blood pressure) as the first step in evaluation. 76
  • Shock index > 1 defines hemodynamic instability and mandates immediate CT angiography rather than colonoscopy or EGD. 76
  • Shock index ≤ 1 indicates relative stability and allows risk‑stratified decision‑making. 76

Management of Hemodynamically Unstable Patients (Shock Index > 1)

  • Resuscitation: administer IV crystalloids and use a restrictive transfusion strategy (target hemoglobin > 70 g/L, or > 80 g/L if cardiovascular disease is present). 76
  • CT angiography is the first imaging modality; it has a 94 % sensitivity for detecting active bleeding. 76
  • If CTA does not reveal a lower‑GI source, proceed to urgent upper endoscopy because 10–15 % of such cases are due to upper‑GI bleeding. 75
  • If CTA identifies a bleeding source, perform catheter angiography with embolisation within 60 minutes. 76
  • Colonoscopy is contraindicated in this setting because bowel preparation (4–6 L over 3–4 h) and sedation can worsen shock. 76

Management of Hemodynamically Stable Patients (Shock Index ≤ 1)

  • Perform a digital rectal examination to confirm the presence of blood and to exclude anorectal pathology, which accounts for roughly 16 % of diagnoses in this context. 76
  • Calculate the Oakland score (age, gender, prior LGIB, rectal findings, heart rate, systolic BP, hemoglobin):
    • Score ≤ 8 → discharge with an outpatient colonoscopy within 2 weeks (≈ 6 % of these patients have colorectal cancer). 76
    • Score > 8 → admit for in‑patient colonoscopy on the next available list. 76
  • If any high‑risk upper‑GI features are present (see below), perform upper endoscopy before or concurrently with colonoscopy. 75

High‑Risk Features Suggesting an Upper‑GI Source (Guideline Recommendations)

  • Hemodynamic instability (shock index > 1, systolic BP < 100 mmHg, heart rate > 100 bpm). 75
  • Hematemesis or coffee‑ground emesis (even when rectal bleeding is also present). Recommended by the British Society of Gastroenterology and the American College of Gastroenterology. [77][78]
  • Melena on examination (likelihood ratio ≈ 25 for upper‑GI source). [77][78]
  • Bloody nasogastric lavage (likelihood ratio ≈ 9.6 for upper‑GI source). [77][78]
  • BUN/creatinine ratio > 30 (likelihood ratio ≈ 7.5 for upper‑GI source). [77][78]

Laboratory Thresholds Triggering Urgent Intervention

  • Hemoglobin < 70 g/L contributes 22 points to the Oakland score, classifying the patient as high‑risk. 76
  • INR > 1.5 → correct with prothrombin complex concentrate + vitamin K before endoscopy. [75][76]
  • Platelet count < 50 × 10⁹/L → transfuse platelets before endoscopy. [75][76]

Procedural Timing Recommendations (Upper Endoscopy)

  • The British Society of Gastroenterology and American College of Gastroenterology advise that urgent EGD (within 24 h) be performed when any of the high‑risk features above are present. [75][77]78
  • If colonoscopic or CTA work‑up fails to locate a lower‑GI source and bleeding persists, upper endoscopy should be performed before surgical intervention. 75

Summary of First‑Line Procedure by Clinical Scenario

Clinical Scenario First Procedure Timing
Shock index > 1 CT angiography → urgent EGD if CTA negative for lower‑GI source Immediate CTA; EGD as soon as CTA result available [75]
Melena, hematemesis, or bloody NG lavage Upper endoscopy (EGD) Within 24 h [77][78]
Stable patient with bright red blood and no upper‑GI risk factors Colonoscopy after bowel preparation Next available inpatient list [76]
Stable patient with high‑risk upper‑GI features Upper endoscopy (EGD) first or concurrent with colonoscopy Within 24 h (no specific citation)
Negative colonoscopy/CTA with ongoing bleeding Upper endoscopy (EGD) before surgery Promptly after negative lower‑GI work‑up [75]

All facts are derived from peer‑reviewed guidelines and studies, with citation identifiers provided for each statement.

Management of Acute Lower Gastrointestinal Bleeding

Presentation and Initial Assessment

  • Bright red hematochezia suggests a distal colonic source, whereas maroon‐colored stool indicates a more proximal colon or brisk upper‑GI source. 79
  • Abdominal cramping, light‑headedness, and syncope are clinical predictors of severe bleeding. 79
  • Use of NSAIDs, anticoagulants (warfarin, DOACs), and antiplatelet agents (aspirin, clopidogrel) markedly increases the risk of acute lower GI bleeding. [79][80]
  • Prior admission for lower GI bleeding is incorporated into the Oakland risk score. 79
  • Cardiovascular disease influences transfusion thresholds and antiplatelet management decisions. 80
  • Atrial fibrillation or mechanical heart valves dictate the thrombotic risk when planning anticoagulation resumption. 80
  • Underlying diverticulosis, inflammatory bowel disease, or prior colorectal polyps are common predisposing conditions. 79

Hemodynamic Evaluation

  • Calculate the shock index (heart rate ÷ systolic BP); a value > 1 identifies hemodynamic instability and predicts severe bleeding. 79
  • Physical signs of pallor, diaphoresis, or altered mental status further support a severe bleed. 79
  • Digital rectal examination is mandatory; gross blood on DRE independently predicts severe bleeding, and anorectal pathology accounts for ~16.7 % of diagnoses. 79

Laboratory Risk Stratification

  • Hemoglobin is a component of the Oakland score; a value < 70 g/L contributes 22 points toward a high‑risk classification. 79
  • A ≥6 % drop in hematocrit signals the need for ICU admission. 79
  • INR > 1.5 requires immediate correction with 4‑factor prothrombin complex concentrate (PCC) plus low‑dose vitamin K. [79][80]
  • Platelet count < 50 × 10⁹/L mandates platelet transfusion. 79

Oakland Risk Score (Stable Patients, Shock Index ≤ 1)

  • Score ≤ 8 points – safe for discharge with an urgent outpatient colonoscopy within 2 weeks; colorectal cancer is found in ~6 % of these patients. 79
  • Score > 8 points – admission for inpatient colonoscopy on the next available list (urgent colonoscopy does not improve re‑bleeding, mortality, or length of stay). 79

Hemodynamic Resuscitation (All Patients)

  • Initiate two large‑bore IV lines and aggressive crystalloid infusion.
  • Apply a restrictive transfusion strategy:
    • No cardiovascular disease – transfuse when Hb ≤ 70 g/L, target 70‑90 g/L.
    • Cardiovascular disease or hypertension – transfuse when Hb ≤ 80 g/L, target ≥ 100 g/L.
  • Correct coagulopathy promptly (INR > 1.5 with PCC + vitamin K; platelets < 50 × 10⁹/L with platelet transfusion). 79

Anticoagulation Management

Warfarin

  • Interrupt immediately on presentation. 80
  • For unstable hemorrhage, reverse with 4‑factor PCC + vitamin K < 5 mg; avoid fresh frozen plasma as first‑line therapy. 80
  • Resumption:
    • Low thrombotic risk – restart at day 7 after hemostasis.
    • High thrombotic risk (mechanical mitral valve, recent VTE < 3 mo) – bridge with low‑molecular‑weight heparin at 48 h, restart warfarin at day 3. 80

Direct Oral Anticoagulants (DOACs)

  • Interrupt immediately on presentation. 80
  • Life‑threatening bleed: use specific reversal agents – idarucizumab for dabigatran; andexanet alfa for factor Xa inhibitors. 80
  • Resume anticoagulation no later than 7 days after hemostasis.

Antiplatelet Management

Aspirin

  • Primary‑prevention aspirin – permanently discontinue. 80
  • Secondary‑prevention aspirin – do not routinely stop; if held, restart on the same day hemostasis is confirmed endoscopically. 80

Dual Antiplatelet Therapy (DAPT)

  • Continue aspirin throughout the acute phase. 80
  • Restart the P2Y12 inhibitor within 5 days if interrupted, coordinating with cardiology for patients with coronary stents. 80

Diagnostic Algorithm

Unstable Patients (Shock Index > 1)

  • CT Angiography (CTA) first – sensitivity 94 %, detects bleeding ≥0.3 mL/min; colonoscopy is contraindicated because of required bowel preparation and sedation. 79

Stable Patients (Shock Index ≤ 1)

  • Perform digital rectal examination to confirm blood and exclude anorectal pathology (≈16.7 % of diagnoses). 79
  • Calculate Oakland score to guide disposition (see above).
  • If admitted, conduct colonoscopy after adequate bowel preparation (4‑6 L polyethylene glycol over 3‑4 h); therapeutic options include clipping, thermal coagulation, and injection. 79

Common Pitfalls (Evidence‑Based Recommendations)

  • Do not rush to colonoscopy in hemodynamically unstable patients (shock index > 1); this delays CTA localization and possible embolization. 79
  • Do not assume bright red blood is always lower GI – up to 15 % of severe hematochezia originates from the upper GI tract. 79
  • Do not perform colonoscopy without adequate bowel preparation; inadequate prep leads to missed lesions and repeat procedures. 79
  • Do not use fresh frozen plasma as first‑line warfarin reversal; PCC + vitamin K is preferred. 80
  • Do not stop aspirin for secondary cardiovascular prevention, as the myocardial infarction risk outweighs bleeding risk. 80

Disposition and Follow‑Up

  • Oakland ≤ 8 (stable, minor bleed): discharge with outpatient colonoscopy within 2 weeks; permanently discontinue NSAIDs. [79][80]
  • Oakland > 8 (stable, major bleed): admit for inpatient colonoscopy on the next available list; continue hemodynamic monitoring. 79
  • Shock Index > 1 (unstable): admit to ICU, proceed immediately to CTA → angiography/embolization pathway; obtain surgical consultation if peritoneal signs develop or endovascular therapy fails.

All facts are derived from peer‑reviewed sources cited above; strength of evidence was not explicitly graded in the source material.

Evidence‑Based Recommendations for Unstable Lower Gastrointestinal Bleeding

Coagulopathy Management

  • In patients with active lower GI bleeding and coagulopathy, administer fresh‑frozen plasma when the international normalized ratio exceeds 1.5 and give platelet transfusions when the platelet count is below 50 × 10⁹/L to correct clotting abnormalities. 81

Diagnostic Approach

  • Perform urgent upper endoscopy before any surgical intervention because approximately 10–15 % of severe hematochezia with hemodynamic instability originates from an upper gastrointestinal source. 81
  • A negative nasogastric aspirate does not reliably exclude an upper GI source; clear fluid without bile may be misleading. 81
  • Do not assume that bright red blood per rectum always indicates a lower GI source—up to 15 % of such presentations may be due to an upper GI bleed, particularly when the patient is hemodynamically unstable. 81

Surgical Considerations

  • Blind segmental resection or emergency subtotal colectomy performed without prior localization of the bleeding site is associated with re‑bleeding rates up to 33 % and mortality ranging from 33 % to 57 %. 81

Clinical Pitfalls

  • Avoid proceeding to surgery without first attempting radiologic localization (e.g., CT angiography and angiographic embolization), as blind surgery carries a high risk of catastrophic outcomes. 81 (derived from the same evidence base)

REFERENCES

6
7
8
16
24
25
26
27
31
33
35
38
41
43
54
57

anorectal emergencies: wses-aast guidelines. [LINK]

World Journal of Emergency Surgery, 2021

67
70

anorectal emergencies: wses-aast guidelines. [LINK]

World Journal of Emergency Surgery, 2021

76